We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
-1.1%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$8.53B
AUM Growth
+$93.1M
(+1.1%)
Cap. Flow
+$472M
Cap. Flow
% of AUM
5.53%
Top 10 Holdings %
Top 10 Hldgs %
16.89%
Holding
812
New
193
Increased
197
Reduced
149
Closed
231
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Analog Devices
ADI
|
+$188M |
| 2 |
AbbVie
ABBV
|
+$121M |
| 3 |
EA
Electronic Arts
EA
|
+$112M |
| 4 |
Autodesk
ADSK
|
+$97.3M |
| 5 |
Keysight
KEYS
|
+$92.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$123M |
| 2 |
Amphenol
APH
|
+$113M |
| 3 |
Cencora
COR
|
+$108M |
| 4 |
Microsoft
MSFT
|
+$104M |
| 5 |
HP
HPQ
|
+$91.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.52% |
| 2 | Technology | 26.19% |
| 3 | Industrials | 9.44% |
| 4 | Energy | 7.95% |
| 5 | Consumer Discretionary | 5.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Cinemark Holdings
CNK
$4.32B
| $680K | 0.01% |
+37,033
| New | +$620K |
|
477
Generac Holdings
GNRC
$12.5B
| $665K | 0.01% |
6,107
+2,560
| +72% | +$317K |
|
478
Hewlett Packard
HPE
$70.5B
| $658K | 0.01% |
+37,910
| New | +$652K |
|
|
IGMS
479
DELISTED
IGM Biosciences
IGMS
| $626K | 0.01% |
75,000
| – | – |
|
480
Prelude Therapeutics
PRLD
$390M
| $618K | 0.01% |
200,000
-48,000
| -19% | -$180K |
|
|
OLO
481
DELISTED
Olo Inc
OLO
| $589K | 0.01% |
97,148
+47,433
| +95% | +$310K |
|
|
ROVR
482
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $588K | 0.01% |
+93,955
| New | +$561K |
|
483
Clear Secure
YOU
$5.28B
| $576K | 0.01% |
+30,268
| New | +$671K |
|
484
Veeco
VECO
$3.23B
| $571K | 0.01% |
20,330
-31,210
| -61% | -$860K |
|
485
Nuveen Preferred & Income Opportunities Fund
JPC
$2.9B
| $565K | 0.01% |
89,312
-177,839
| -67% | -$1.15M |
|
486
Toast
TOST
$19.9B
| $554K | 0.01% |
+29,600
| New | +$643K |
|
|
JPT
487
DELISTED
Nuveen Preferred and Income Fund
JPT
| $543K | 0.01% |
34,614
-1,628
| -4% | -$26K |
|
488
HealthEquity
HQY
$8.75B
| $533K | 0.01% |
+7,300
| New | +$493K |
|
489
Calix
CALX
$2.39B
| $531K | 0.01% |
11,583
-4,306
| -27% | -$195K |
|
490
PubMatic
PUBM
$810M
| $522K | 0.01% |
43,110
+21,138
| +96% | +$322K |
|
|
NXJ
491
DELISTED
Nuveen New Jersey Quality Municipal Income Fund
NXJ
| $503K | 0.01% |
+47,589
| New | +$537K |
|
|
HCP
492
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $499K | 0.01% |
+21,874
| New | +$594K |
|
493
Concentrix
CNXC
$1.57B
| $497K | 0.01% |
6,199
+1,722
| +38% | +$135K |
|
494
Syndax Pharmaceuticals
SNDX
$1.82B
| $495K | 0.01% |
34,067
-578,249
| -94% | -$10.9M |
|
|
PNT
495
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $492K | 0.01% |
+73,796
| New | +$613K |
|
|
ALLK
496
DELISTED
Allakos
ALLK
| $484K | 0.01% |
+213,422
| New | +$792K |
|
497
Seres Therapeutics
MCRB
$48.4M
| $476K | 0.01% |
10,000
-2,180
| -18% | -$166K |
|
498
Nutanix
NTNX
$16.9B
| $472K | 0.01% |
13,532
-1,350,160
| -99% | -$42.4M |
|
|
ENFN
499
DELISTED
Enfusion, Inc.
ENFN
| $471K | 0.01% |
+52,533
| New | +$499K |
|
|
BAND
500
Bandwidth Inc
BAND
$1.61B
| $469K | 0.01% |
+41,584
| New | +$567K |
|
Similar funds
TCIIS
UIM
VAI
KK
Woodline Partners's Q3 2023 Portfolio in Review
As of Q3 2023, Woodline Partners held 812 positions worth $8.53B, up 1.1% from $8.44B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Woodline Partners deployed $472M of net new capital in Q3 2023, opening 193 new positions and adding to 197 existing holdings. Its largest new stake was Analog Devices: 1,016,972 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 38% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Hess, an estimated $123M trimmed.
- Woodline Partners's largest Q3 2023 buy was Analog Devices: 1,016,972 shares worth $178M.
- Woodline Partners added most to AbbVie in Q3 2023, an estimated $121M increase.
- Woodline Partners's biggest Q3 2023 reduction was Hess, cutting an estimated $123M.
- Woodline Partners fully exited HP in Q3 2023, selling an estimated $91.2M.
- Woodline Partners's ten largest holdings make up 17% of its $8.53B portfolio in Q3 2023.
- Woodline Partners opened 193 new positions and closed 231 in Q3 2023.
- Woodline Partners's portfolio value rose 1.1% quarter-over-quarter to $8.53B.
Based on Woodline Partners's 13F filing for Q3 2023, filed 14 Nov 2023.